AZD0780 Evidence: Trial Results and Peer-Reviewed Publications

Hipa.ai Research · Source: PubMed & ClinicalTrials.gov / AACT · Last updated: May 12, 2026

The clinical evidence base for AZD0780 comprises 1 peer-reviewed publications across 1 journals, 0 pivotal-trial primary-outcome rows reported to ClinicalTrials.gov, spanning indications including Dyslipidemias. Most recent publication: An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial., J Am Coll Cardiol, 2025.

Top peer-reviewed publications

Curated set of pivotal-trial result papers and recent publications in high-tier journals.

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial.
Koren MJ, Vega RB, Agrawal N, et al. · J Am Coll Cardiol · 2025
PubMed: PMID 40167413 · NCT06173570 (PURSUIT) · Dyslipidemias

Publications by year

2025–2025: 1 publications.

2025

Publications by indication

Dyslipidemias (1)

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial.
J Am Coll Cardiol · 2025 · PMID 40167413 · NCT06173570

Publications by journal

J Am Coll Cardiol1 paper

All AZD0780 publications (1)

2025 (1 paper)

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial.
Koren MJ, Vega RB, Agrawal N, et al. · J Am Coll Cardiol · 2025 · Derived
PubMed: PMID 40167413 · NCT06173570 (PURSUIT) · Dyslipidemias

Sources and methodology

Publications: ctgov.study_references (PubMed PMIDs auto-attached by ClinicalTrials.gov to each trial), reference types RESULT, DERIVED, and BACKGROUND.
Per-arm outcome values: ctgov.outcome_measurements joined to ctgov.design_outcomes where outcome_type = 'PRIMARY', restricted to phase PHASE3 and PHASE2/PHASE3.
Publication metadata (title, journal, year, authors): PubMed E-utilities efetch.fcgi
Data freshness: Tue, 12 May 2026 16:52:17 GMT.

This page summarizes published evidence for general reference and does not constitute medical advice. For clinical decisions, consult the linked primary publications and your healthcare provider. Data sourced from PubMed and the ClinicalTrials.gov / AACT database maintained by the Clinical Trials Transformation Initiative (CTTI).